Leishmaniasis is a parasitic, widespread, and neglected disease that affects more than 90
countries in the world. More than 20 Leishmania species cause different forms of …

Cutaneous leishmaniasis (CL) is caused by different species of the genus Leishmania. Pro-
and anti-inflammatory cytokines play different roles in resistance/susceptibility and the …

Advances in the understanding of leishmaniasis progression indicate that cellular
interactions more complex than the Th1/Th2 paradigm define the course of infection. Th17 …

Leishmaniasis is a zoonotic and vector-borne infectious disease that is caused by the genus
Leishmania belonging to the trypanosomatid family. The protozoan parasite has a digenetic …

Leishmaniases are neglected diseases, caused by intracellular protozoan parasites of the
Leishmania (L.) genus. Although the principal host cells of the parasites are macrophages …

The protozoan Leishmania braziliensis causes cutaneous leishmaniasis (CL) in endemic
regions. In murine models, neutrophils (PMNs) are recruited to the site of infection soon after …

Ethnopharmacological relevance Leishmaniasis are widely distributed among tropical and
subtropical countries, and remains a crucial health issue in Amazonia. Indigenous groups …

Leishmania amazonensis is the etiological agent of diffuse cutaneous leishmaniasis. The
immunopathology of leishmaniasis caused by L. amazonensis infection is dependent on the …

Leishmaniasis is a neglected disease caused by an intracellular protozoan parasite of the
genus Leishmania. Infection starts when this protozoan replicates in a phagolysosomal …

Epidemiological studies have been conducted to better understand the dynamics of
American Cutaneous Leishmaniasis (ACL) in the Amazon region where distinct species of …